Noemi Mergen

Affiliations

Amgen Research (Munich) GmbH, Munich, Germany.

Réseau de co-auteurs

Gerhard Zugmaier 3 collaborations

Franco Locatelli 2 collaborations

William N Kormany 2 collaborations

Peter Bader 1 collaboration

Sima Jeha 1 collaboration

Paul-Gerhardt Schlegel 1 collaboration

Jean-Pierre Bourquin 1 collaboration

Rupert Handgretinger 1 collaboration

Benoit Brethon 1 collaboration

Claudia Rössig 1 collaboration

Puneeth Viswagnachar 1 collaboration

Christiane Chen-Santel 1 collaboration

Nicola Gökbuget 1 collaboration

Hervé Dombret 1 collaboration

Anthony Stein 1 collaboration

Massimiliano Bonifacio 1 collaboration

Carlos Graux 1 collaboration

Christoph Faul 1 collaboration

Monika Brüggemann 1 collaboration

Kate Taylor 1 collaboration

Albrecht Reichle 1 collaboration

Heinz-August Horst 1 collaboration

Violaine Havelange 1 collaboration

Max S Topp 1 collaboration

Ralf C Bargou 1 collaboration

Carmelo Rizzari 1 collaboration

Joan D Morris 1 collaboration

Bernd Gruhn 1 collaboration

Thomas Klingebiel 1 collaboration

Rosanna Parasole 1 collaboration

Christin Linderkamp 1 collaboration

Christian Flotho 1 collaboration

Arnaud Petit 1 collaboration

Concetta Micalizzi 1 collaboration

Abeera Mohammad 1 collaboration

Cornelia Eckert 1 collaboration

Anja Möricke 1 collaboration

Mary Sartor 1 collaboration

Ondrej Hrusak 1 collaboration

Christina Peters 1 collaboration

Vaskar Saha 1 collaboration

Luciana Vinti 1 collaboration

Arend von Stackelberg 1 collaboration

Noemi Mergen

Affiliations

Publications (3)

Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis.

Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia.

Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

Réseau de co-auteurs